As of 2026-01-01, the Relative Valuation of Esperion Therapeutics Inc (ESPR) is (7.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.70 USD, the upside of Esperion Therapeutics Inc based on Relative Valuation is -311.2%.
The range of the Relative Valuation is (7.37) - (7.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 21.8x | 17.7x |
| Forward P/E multiples | 16.6x - 17.8x | 17.6x |
| Fair Price | (7.37) - (7.90) | (7.81) |
| Upside | -299.1% - -313.5% | -311.2% |
| Date | P/E |
| 2025-12-26 | -9.13 |
| 2025-12-24 | -8.92 |
| 2025-12-23 | -8.76 |
| 2025-12-22 | -9.13 |
| 2025-12-19 | -8.88 |
| 2025-12-18 | -8.58 |
| 2025-12-17 | -8.24 |
| 2025-12-16 | -8.38 |
| 2025-12-15 | -8.54 |
| 2025-12-12 | -8.70 |
| 2025-12-11 | -9.22 |
| 2025-12-10 | -8.65 |
| 2025-12-09 | -8.56 |
| 2025-12-08 | -8.83 |
| 2025-12-05 | -8.43 |
| 2025-12-04 | -8.56 |
| 2025-12-03 | -8.54 |
| 2025-12-02 | -8.27 |
| 2025-12-01 | -8.40 |
| 2025-11-28 | -9.06 |
| 2025-11-26 | -8.92 |
| 2025-11-25 | -8.34 |
| 2025-11-24 | -7.16 |
| 2025-11-21 | -6.96 |
| 2025-11-20 | -6.66 |
| 2025-11-19 | -6.30 |
| 2025-11-18 | -6.39 |
| 2025-11-17 | -6.37 |
| 2025-11-14 | -6.55 |
| 2025-11-13 | -6.69 |
| 2025-11-12 | -6.84 |
| 2025-11-11 | -7.00 |
| 2025-11-10 | -6.51 |
| 2025-11-07 | -6.01 |
| 2025-11-06 | -5.65 |
| 2025-11-05 | -6.64 |
| 2025-11-04 | -6.44 |
| 2025-11-03 | -6.66 |
| 2025-10-31 | -6.71 |
| 2025-10-30 | -6.42 |
| 2025-10-29 | -6.48 |
| 2025-10-28 | -6.87 |
| 2025-10-27 | -6.55 |
| 2025-10-24 | -6.12 |
| 2025-10-23 | -6.05 |
| 2025-10-22 | -6.14 |
| 2025-10-21 | -6.30 |
| 2025-10-20 | -6.37 |
| 2025-10-17 | -6.21 |
| 2025-10-16 | -5.99 |